Abiopharma

🔍 Malloy Lavell Juan II (Director)

Company: Brag House Holdings, Inc. (TBH)

Report Date: 2026-03-18

Detailed Transactions and Holdings:

• Acquired 570,778 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 980,851.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 570,778 shares of Stock Option (right to buy) (Derivative)
  Date: 2026-03-18 | Code: H | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F1, F3, F3
• Acquired 570,778 shares of Restricted Stock Unit (Derivative)
  Date: 2026-03-18 | Code: A | Exercise: 2026-03-18 | equity_swap_involved: 0 | shares_owned_after: 570,778.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 570,778 shares of Restricted Stock Unit (Derivative)
  Date: 2026-03-18 | Code: C | Exercise: 2026-03-18 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: On March 18, 2026, the Board of Directors (the "Board") approved a corrective action whereby the Company and the Reporting Person agreed to mutually cancel all outstanding stock option awards held by the Reporting Person, consisting of 570,778 shares subject to the options held and issue 570,778 restricted stock units ("RSUs") in lieu of the number of shares underlying the cancelled stock options.
• F2: These securities are RSUs, which were issued pursuant to the Company's 2024 Omnibus Incentive Plan. The RSUs are fully vested and immediately exercisable.
• F3: 347,222 of the stock options had an exercise price of $0.576 per share, were exercisable in accordance with the vesting schedule, and were set to expire on March 5, 2035. The remaining 223,556 stock options had an exercise price of $1 per share, were exercisable immediately and were set to expire on July 18, 2030.
• F4: The RSUs do not expire, they either vest or are canceled prior to vesting date.